- call +1-201-465-4211
- email sales@mrinsights.biz
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
Scope of the Report:
Geographically, North America is the world's largest extracorporeal diagnostic market. Europe and the United States together account for more than 65 percent of the global market. Japan has the largest share of the Asian in vitro diagnosis market, with an 8.73% market share.
The global IVD Infectious Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of IVD Infectious Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the IVD Infectious Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the IVD Infectious Disease market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche Diagnostics
Abbott Laboratories
Alere
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Market Segment by Applications, can be divided into
Personal
Commercial
Academic
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 IVD Infectious Disease Market Overview
1.1 Product Overview and Scope of IVD Infectious Disease
1.2 Classification of IVD Infectious Disease by Types
1.2.1 Global IVD Infectious Disease Revenue Comparison by Types (2017-2023)
1.2.2 Global IVD Infectious Disease Revenue Market Share by Types in 2017
1.2.3 Biochemical Diagnosis
1.2.4 Immune Diagnosis
1.2.5 Molecular Diagnosis
1.2.6 Microbiological Diagnosis
1.2.7 Urine Diagnosis
1.2.8 Coagulation Diagnosis
1.2.9 Other
1.3 Global IVD Infectious Disease Market by Application
1.3.1 Global IVD Infectious Disease Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Personal
1.3.3 Commercial
1.3.4 Academic
1.3.5 Other
1.4 Global IVD Infectious Disease Market by Regions
1.4.1 Global IVD Infectious Disease Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) IVD Infectious Disease Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) IVD Infectious Disease Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) IVD Infectious Disease Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) IVD Infectious Disease Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) IVD Infectious Disease Status and Prospect (2013-2023)
1.5 Global Market Size of IVD Infectious Disease (2013-2023)
2 Manufacturers Profiles
2.1 Roche Diagnostics
2.1.1 Business Overview
2.1.2 IVD Infectious Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Diagnostics IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott Laboratories
2.2.1 Business Overview
2.2.2 IVD Infectious Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 Alere
2.3.1 Business Overview
2.3.2 IVD Infectious Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Alere IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Gen-Probe
2.4.1 Business Overview
2.4.2 IVD Infectious Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Gen-Probe IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Becton Dickinson (BD)
2.5.1 Business Overview
2.5.2 IVD Infectious Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Becton Dickinson (BD) IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bio-Rad Laboratories
2.6.1 Business Overview
2.6.2 IVD Infectious Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Rad Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Siemens Healthcare
2.7.1 Business Overview
2.7.2 IVD Infectious Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Siemens Healthcare IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biomérieux
2.8.1 Business Overview
2.8.2 IVD Infectious Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biomérieux IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Danaher
2.9.1 Business Overview
2.9.2 IVD Infectious Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Danaher IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.10 Thermo Fisher
2.10.1 Business Overview
2.10.2 IVD Infectious Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Thermo Fisher IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sysmex
2.11.1 Business Overview
2.11.2 IVD Infectious Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sysmex IVD Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
3 Global IVD Infectious Disease Market Competition, by Players
3.1 Global IVD Infectious Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 IVD Infectious Disease Players Market Share
3.2.2 Top 10 IVD Infectious Disease Players Market Share
3.3 Market Competition Trend
4 Global IVD Infectious Disease Market Size by Regions
4.1 Global IVD Infectious Disease Revenue and Market Share by Regions
4.2 North America IVD Infectious Disease Revenue and Growth Rate (2013-2018)
4.3 Europe IVD Infectious Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific IVD Infectious Disease Revenue and Growth Rate (2013-2018)
4.5 South America IVD Infectious Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa IVD Infectious Disease Revenue and Growth Rate (2013-2018)
5 North America IVD Infectious Disease Revenue by Countries
5.1 North America IVD Infectious Disease Revenue by Countries (2013-2018)
5.2 USA IVD Infectious Disease Revenue and Growth Rate (2013-2018)
5.3 Canada IVD Infectious Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico IVD Infectious Disease Revenue and Growth Rate (2013-2018)
6 Europe IVD Infectious Disease Revenue by Countries
6.1 Europe IVD Infectious Disease Revenue by Countries (2013-2018)
6.2 Germany IVD Infectious Disease Revenue and Growth Rate (2013-2018)
6.3 UK IVD Infectious Disease Revenue and Growth Rate (2013-2018)
6.4 France IVD Infectious Disease Revenue and Growth Rate (2013-2018)
6.5 Russia IVD Infectious Disease Revenue and Growth Rate (2013-2018)
6.6 Italy IVD Infectious Disease Revenue and Growth Rate (2013-2018)
7 Asia-Pacific IVD Infectious Disease Revenue by Countries
7.1 Asia-Pacific IVD Infectious Disease Revenue by Countries (2013-2018)
7.2 China IVD Infectious Disease Revenue and Growth Rate (2013-2018)
7.3 Japan IVD Infectious Disease Revenue and Growth Rate (2013-2018)
7.4 Korea IVD Infectious Disease Revenue and Growth Rate (2013-2018)
7.5 India IVD Infectious Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia IVD Infectious Disease Revenue and Growth Rate (2013-2018)
8 South America IVD Infectious Disease Revenue by Countries
8.1 South America IVD Infectious Disease Revenue by Countries (2013-2018)
8.2 Brazil IVD Infectious Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina IVD Infectious Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia IVD Infectious Disease Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue IVD Infectious Disease by Countries
9.1 Middle East and Africa IVD Infectious Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia IVD Infectious Disease Revenue and Growth Rate (2013-2018)
9.3 UAE IVD Infectious Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt IVD Infectious Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria IVD Infectious Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa IVD Infectious Disease Revenue and Growth Rate (2013-2018)
10 Global IVD Infectious Disease Market Segment by Type
10.1 Global IVD Infectious Disease Revenue and Market Share by Type (2013-2018)
10.2 Global IVD Infectious Disease Market Forecast by Type (2018-2023)
10.3 Biochemical Diagnosis Revenue Growth Rate (2013-2023)
10.4 Immune Diagnosis Revenue Growth Rate (2013-2023)
10.5 Molecular Diagnosis Revenue Growth Rate (2013-2023)
10.6 Microbiological Diagnosis Revenue Growth Rate (2013-2023)
10.7 Urine Diagnosis Revenue Growth Rate (2013-2023)
10.8 Coagulation Diagnosis Revenue Growth Rate (2013-2023)
10.9 Other Revenue Growth Rate (2013-2023)
11 Global IVD Infectious Disease Market Segment by Application
11.1 Global IVD Infectious Disease Revenue Market Share by Application (2013-2018)
11.2 IVD Infectious Disease Market Forecast by Application (2018-2023)
11.3 Personal Revenue Growth (2013-2018)
11.4 Commercial Revenue Growth (2013-2018)
11.5 Academic Revenue Growth (2013-2018)
11.6 Other Revenue Growth (2013-2018)
12 Global IVD Infectious Disease Market Size Forecast (2018-2023)
12.1 Global IVD Infectious Disease Market Size Forecast (2018-2023)
12.2 Global IVD Infectious Disease Market Forecast by Regions (2018-2023)
12.3 North America IVD Infectious Disease Revenue Market Forecast (2018-2023)
12.4 Europe IVD Infectious Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific IVD Infectious Disease Revenue Market Forecast (2018-2023)
12.6 South America IVD Infectious Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa IVD Infectious Disease Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure IVD Infectious Disease Picture
Table Product Specifications of IVD Infectious Disease
Table Global IVD Infectious Disease and Revenue (Million USD) Market Split by P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
